Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer
Clinical trial NCT07359040 · RECRUITING
Trial details
- NCT number
- NCT07359040
- Sponsor
- Peking University People's Hospital
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-07-01
- Primary completion
- 2026-12-21
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.